Beckman Research Institute of City of Hope

Total Awards: 
14
Award Value: 
$55,090,333
Institution type: 
Not for profit

Awards to the Institution

Award Value
Tools and Technologies I: Larry Couture Discovery and optimization of small molecules for stem cell fate regulation $882,929
Tools and Technologies I: Larry Couture Development of Suspension Adaptation, Scale-up cGMP Banking and Cell Characterization Technologies for hESC Lines $882,929
Tools and Technologies I: Larry Couture Development of Prognostic, Therapy Selection and Therapy Targeting Markers for Adult Breast Cancer Peripheral Blood Stem Cells. $882,929
Tools and Technologies I: Larry Couture Development of Optimal Approaches for Genomic Engineering of Human Stem Cells $882,929
SEED Grant: Timothy O'Connor Treatment of Lung Disease with Inhaled Stem Cells $327,311
SEED Grant: Timothy O'Connor Differentiation of Human Embryonic Stem Cells to Heart Cells $327,311
New Faculty I: Tiziano Barberi Reprogramming the Cancer Genome $131,840
Early Translational II: David DiGiusto Smart Nerve Condiuts: A Regulated NGF Delivery System Based on Triple Transfected ADSC's $3,124,130
Early Translational II: Yanhong Shi New Drug Discovery for ALS using Patient-derived Induced Pluripotent Stem Cells $1,835,983
Early Translational II: Yanhong Shi Novel Remyelination Approaches Using Human Schwann Cell Precursors $1,835,983
Early Translational II: Yanhong Shi Osteoregenerative Drug Candidates to Repair Bone, Improve Healing and Reduce Medical Costs $1,835,983
Basic Biology III: Jiing-Kuan Yee Mechanism of selective induction of apoptosis in leukemic stem cells by antibodies to EphA3 $1,268,868
Basic Biology III: Jiing-Kuan Yee Dissecting the molecular basis of mesoderm formation $1,268,868
Basic Biology III: Jiing-Kuan Yee Mechanobiology of aged stem cells: A foundation for improved musculoskeletal healing in the elderly $1,268,868
Early Translational III: Stephen Forman Neurosteroid Activation of Endogenous Neural Stem Cells for Neonatal Brain Damage Repair $5,217,004
Basic Biology IV: Yanhong Shi Molecular Regulation of Stem Cell Quiescence $1,367,172
Basic Biology IV: Yanhong Shi Characterization of retinal precursor cells using pluripotent stem cell-derived cultures $1,367,172
Research Leadership 14: John Zaia Rejuvenation of human skeletal muscle stem cell function during aging, injury and disease $5,583,438
Research Leadership 14: John Zaia Modulation of the regenerative niche: an improved platform toward clinical trials $5,583,438
Disease Team Research I: John Zaia Liver Disease Team $14,573,835
Disease Team Research I: John Zaia Develop a cell replacement therapy for Parkinson’s disease using human embryonic stem cells $14,573,835
Disease Team Research I: Karen Aboody CNS Derived Stem Cells for the Treatment of Thoracic and Cervical Spinal Cord Injury $18,015,429
Early Translational II: David DiGiusto Development of RNA-based approaches to stem cell gene therapy for HIV $3,124,130
Disease Team Research I: Karen Aboody Stem Cell-mediated Therapy for High-grade Glioma: Toward Phase I-II Clinical Trials $18,015,429
Disease Team Research I: John Zaia ZINC FINGER NUCLEASE-BASED STEM CELL THERAPY FOR AIDS $14,573,835
SEED Grant: Timothy O'Connor Sources of Genetic Instability in Human Embryonic Stem Cells. $327,311
New Faculty I: Tiziano Barberi Skeletal muscle development from hESC and its in vivo applications in animal models of muscular dystrophy $131,840
Basic Biology III: Jiing-Kuan Yee Use of human iPS cells to study spinal muscular atrophy $1,268,868
Research Training II: Michael Barish City of Hope Research Training Program in Stem Cell Biology $2,500,143
Early Translational III: Stephen Forman Targeting glioma cancer stem cells with receptor-engineered self-renewing memory T cells $5,217,004
Basic Biology IV: Yanhong Shi Modeling Alexander disease using patient-specific induced pluripotent stem cells $1,367,172
Creativity Awards: Paul Salvaterra Creativity Award Program in Stem Cell Biology for California High School Students $207,251
Disease Team Planning: Michael Barish Genetically-modified neural stem cells for treatment of high-grade glioma $55,000
Strategic Partnership III Track A: John Zaia A PHASE I, OPEN-LABEL STUDY TO ASSESS THE SAFETY, FEASIBILITY AND ENGRAFTMENT OF ZINC FINGER NUCLEASES (ZFN) CCR5 MODIFIED AUTOLOGOUS CD34+ HEMATOPOIETIC STEM/PROGENITOR CELLS (SB-728mR-HSPC) WITH ESCALATING DOSES OF BUSULFAN IN HIV-1 (R5) INFECTED SUBJEC $5,583,438
Early Translational II: Yanhong Shi Developing a therapeutic candidate for Canavan disease using induced pluripotent stem cell $1,835,983
Disease Team Research I: Karen Aboody CNS Derived Stem Cells for the Treatment of Thoracic and Cervical Spinal Cord Injury $18,015,429
Disease Team Research I: John Zaia Develop a cell replacement therapy for Parkinson’s disease using human embryonic stem cells $14,573,835
Disease Team Research I: John Zaia Liver Disease Team $14,573,835
SEED Grant: Timothy O'Connor Treatment of Lung Disease with Inhaled Stem Cells $327,311
SEED Grant: Timothy O'Connor Differentiation of Human Embryonic Stem Cells to Heart Cells $327,311
Total:
$185,063,309.00
Icon for xls export

© 2013 California Institute for Regenerative Medicine